Here are the Form 4 insider transactions from Lakewood-Amedex Biotherapeutics Inc. (LABT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LABT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LABT filings page.
Lakewood-Amedex Biotherapeutics Inc. director Tucker Joseph Edward received a grant of warrants to acquire 33,784 shares of Common Stock. The warrants carry an exercise price of $10.00 per share and were awarded as a grant/award acquisition, not an open-market purchase.
The warrants vest in four equal tranches of 8,446 warrants on October 24, 2026, April 24, 2027, October 24, 2027, and April 24, 2028, and expire on April 23, 2036. Following this grant, 33,784 derivative securities of this type are reported as directly held.